Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015;13(4):514-23.
doi: 10.2174/1570159x1304150831120428.

Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression

Affiliations
Free PMC article
Review

Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression

Guo-jiang Peng et al. Curr Neuropharmacol. .
Free PMC article

Abstract

Depression is one of the prevalent and persistent psychiatric illnesses. It brings heavy socioeconomic burden such as healthcare expenditures and even higher suicide rates. Despite many hypotheses about its mechanism have been put forward, so far it is still unclear, not to mention the precise and effective diagnostic or therapeutic methods. In this paper, the current conditions of pathological and pharmacological mechanism of depression were reviewed systematically. Firstly, the most recent hypotheses and metabolomics based research including hereditary, neurotransmitter systems, brain derived neurotrophic factor (BDNF), hyperactivity of the hypothalamic pituitary adrenal (HPA) axis and inflammatory as well as metabolomics were summarized. Secondly, the present situation and development on antidepressant drugs at home and abroad were reviewed. Finally, a conclusion and prospect on the pathological and pharmacological mechanism of depression were provided primarily.

Figures

Fig. (1)
Fig. (1)
Stress and HPA axis.
Fig. (2)
Fig. (2)
The general procedures where biomarkers can be discovered via metabolomics.
Fig. (3)
Fig. (3)
The different pathological mechanism of depression.

Similar articles

See all similar articles

Cited by 3 articles

References

    1. Lépine J.P., Briley M. The increasing burden of depression. Neuropsychiatr. Dis. Treat. 2011;7(Suppl. 1):3–7. - PMC - PubMed
    1. Baglioni C., Battagliese G., Feige B., Spiegelhalder K., Nissen C., Voderholzer U., Lombardo C., Riemann D. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J. Affect. Disord. 2011;135(1-3):10–19. doi: 10.1016/j.jad.2011.01.011. - DOI - PubMed
    1. He Y.C., Zhang B. Clinic research progress on depression. Intl. J. Lab. Med. 2013;07:832–834.
    1. Miret M., Ayuso-Mateos J.L., Sanchez-Moreno J., Vieta E. Depressive disorders and suicide: Epidemiology, risk factors, and burden. Neurosci. Biobehav. Rev. 2013;37(10 Pt 1):2372–2374. doi: 10.1016/j.neubiorev.2013.01.008. - DOI - PubMed
    1. Tian J.S., Shi B.Y., Xiang H., Gao S, Qin XM, Du GH. 1HNMR- Based Metabonomic Studies on the Anti-Depressant Effect of Genipin in the Chronic Unpredictable Mild Stress Rat Model. PLoS One. 2013;8(9):e75721. - PMC - PubMed

Publication types

MeSH terms

Substances

Feedback